Journals / Medical Network Klinik Bilimler ve Doktor / 2003 / Cilt: 9 - Sayı: 2

Plasma soluble intercellular adhesion molecule-1 levels in type-II diabetes mellitus and its association with retinopathy

Tip II diabetes mellituslu hastalarda plasma solubl intersellüler adezyon molekülü-1 düzeyleri ve retinopati ile ilişkisi

Pages
129–134
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In order to explain their role, prospective follow up studies made in large population is needed

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to investigate the possible roles of adhesion molecules in pathogenesis of microvascular complications of diabetes mellitus.
📊
Key Findings & Data:Material and Method: 50 type-2 diabetic patients who applied to Ankara Social Security Hospital internal medicine outdoor clinic were involved in the study.
💡
Conclusion & Impact:In order to explain their role, prospective follow up studies made in large population is needed
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diabetes mellitus · insülin bağımsız · Diabetik retinopati

Abstract

Objective: The aim of this study is to investigate the possible roles of adhesion molecules in pathogenesis of microvascular complications of diabetes mellitus. Material and Method: 50 type-2 diabetic patients who applied to Ankara Social Security Hospital internal medicine outdoor clinic were involved in the study. The patients were groupped according to their retinal examinations as the patients without retinopathy, patients with nonproliferative retinopaty and with proliferative retinopathy. Control group was consisted of 25 healthy adults. Fasting and postprandial plasma glucose levels, glycosilated hemoglobine (HbA1C) and soluble intercellular adhesion molecule-1 (sICAM-1) levels were measured in all patients. Results: sICAM-1 levels were statistically significantly higher in diabetic patients when compared with control group (500.986±134.35 ng/ml versus 404.316±104.90 ng/ml, p<0.01). When groupped according to the presence of retinopathy the patients with retinopathy had higher sICAM-1 levels than the patients without retinopathy, and this difference was statistically significant (565.17±117.20 ng/ml vs 431.45±117.56 ng/ml, p<0.01). When compared with nonproliferative retinopathy, proliferative rethinopathy had the highest sICAM-1 level (624.51±114.23 vs 495.94± 78.02 ng/ml, p<0.05) Conclusion: Adhesion molecules may have role in the development of microvascular complications of diabetes mellitus. In order to explain their role, prospective follow up studies made in large population is needed

Özet

Amaç: Tip-2 diabetes mellituslu hastalarda mikrovasküler komplikasyonların gelişiminde adezyon moleküllerinin olası rollerini araştırmak amaçlanmıştır. Gereç ve Yöntem: SSK Ankara Eğitim Hastanesi 3. Dahiliye polikliniğine başvuran tip 2 dibetes mellitusu olan 50 hasta çalışmaya dahil edildi. Hastalar göz dibi muayenelerine göre diabetik retinopatisi olmayan, nonproliferatif retinopatisi ve proliferatif retinopatisi olanlar şeklinde gruplandırıldı. Kontrol grubu herhangi bir hastalığı olmayan 25 kişiden oluştu. Tüm hastaların açlık ve postprandial plazma glukoz düzeyleri, glikozile hemoglobin (HbA1C) düzeyleri ve solubl intersellüler adezyon molekülü-1 (sICAM-1) düzeyleri ölçüldü. Bulgular: Diabetiklerde sICAM-1 düzeyleri, kontrol grubuyla karşılaştırıldığında istatistiksel olarak anlamlı derecede yüksekti (diabetik hastalarda 500.986±134.35 ng/ml, kontrol grubunda 404.316±104.90ng/ml, p<0.01). sICAM-1 düzeyleri retinopatisi olan grupta retinopatisi olmayan gruptan daha yüksekti (retinopatisi olan grupta 565.17±117.20 ng/ml, retinopatisi olmayan grupta 431.45±117.56 ng/ml, p<0.01). Proliferatif retinopatisi olan grupta ise nonproliferatif retinopatisi olan grupla karşılaştırıldığında sICAM-1 düzeyi istatistiksel olarak anlamlı derecede yüksek olarak bulundu (624.51±114.23 ng/ml'e 495.94±78.02 ng/ml, p<0.05) Sonuç: Diabetes mellitusun mikrovasküler komplikasyonlarında adezyon moleküllerinin rolleri olması muhtemeldir. Bu durumu daha iyi açıklayacak geniş hasta popülasyonunda yapılacak prospektif takip çalışmalarına ihtiyaç vardır.

🔖

Cite This Article

YAYAR, Ö. Y., YAYAR, O., DEMİRCİ, H., ERSOY, O., YILDIRIM, İ. S. (2003). Plasma soluble intercellular adhesion molecule-1 levels in type-II diabetes mellitus and its association with retinopathy. Medical Network Klinik Bilimler ve Doktor, Cilt: 9 - Sayı: 2, 129–134. https://ajindex.com/articles/278494

References (13)

  1. Altuntaş Y. Diabetes mellitusun tanımı, tanısı ve sınıflaması. İn; Her Yönüyle Diabetes Mellitus. Nobel Tıp Kitapları İstanbul; 2001; 51-62. Yenigün M. Mikro ve makroanjiopatiler. İn; Kardiyovasküler diabet. İÜ basımevi İstanbul; 1997; 122-50.
  2. Schroder S, Polinski W, Schmid-Schonbein G. Activated mo- nocytes and granulocytes, capillary nonperfusion and neovascu- larisation in diabetic retinopathy. Am. J. Pathol 1991; 139:81 -100. Little HL. Alterations in blood elements in the pathogenesis of diabetic retinopathy. Opthalmology 1981; 88:647-54.
  3. Schmid-Schönbein H, Volger E. Red cell aggregation and red cell deformabilitiy in diabetes. Diabetes 1976; 25:897-902. Frank RN. The aldose reductase controversy. Diabetes 1994; 169-72.
  4. Forrester JV, Knott RM, Mcıntosh LC. Pathogenesis of dia­ betic retinopathy and maculopathy. Elsevier science publishers Amsterdam 1993; 178-91. Kohner EM. Diabetic retinopathy. BMJ 1993; 307:1195-9.
  5. Schimid-Schönbein GW, Sung KP, Tozeran H. Passive mec­ hanical properties of human leucocytes. Biophys J 1981; 36:243-56.
  6. Tanaka Y, Adams DH, Shaw S.Proteoglycans on endothelial cells present adhesion inducing cytokines to leucocytes. Immu­nol Today 1993; 14:111-5. Springer TA. Adhesion receptors of immune system. Nature 1990; 346:425-34.
  7. Adams DH, Shaw S. Leucocyte endothelial interractions and regulation of leucocyte migration. Lancet 1994; 343:831-6.
  8. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 iso-forms: diagnostic prospects for inflammatory and immune disor­ders. Lancet 1991; 338:83-4.
  9. Cominacini L, Fratta Pasini A, Garbin U. elevated levels of soluble E-selectin in patients with IDDM and NIDDM: retation to metabolic control. Diabetologia 1995; 38:1122-4.
  10. Fasching P, Waldhausl W, Wagner OF. Elevated circulating adhesion molecules in NDDM- potential mediators in diabetic macroangiopathy. Diabetologia 1996; 39:1242-4.
  11. Clausen P, Jacobsen P, Rossing K. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with type-1 dia­ betes mellitus with microalbuminuria and overt nephropaty. Dia­ bet Med 2000; 17:644-9.
  12. Albertini JP, Valensip, Lormeau B. Soluble L-Selectin is a marker of coronary artery disease in type 2 diabetic patients. Diabetes Care 1999; 22:2044-8.
  13. Devaraj S, Jialal J. Low density lipoprotein postsecratory mo­ dification, monocyte function and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular comp­ lications: effect of alpha tocopherol supplementation. Circulation 200